Ixaltis

Developing innovative treatments for genitourinary tract disorders

Total raised

€11M

€10,800,000

Funding rounds

Investors

distinct backers

Active since

2016-04

latest 2016-04

Funding by year

EUR raised per year

Medium confidence

Raise-next likelihood15

base rate 45% for Debt

Exit likelihood13

base rate 12% (2+ rounds)

Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.

2 rounds

Date	Stage	Amount	Investors
2016-05-01	Debt	€2.8M	—	View deal →
2016-05-01	Series A	€8.0M	IRDInov,iXO Private Equity,Principia SGR,Sofimac Partners	View deal →

same sector or country